
Old Yellow Enzymes Protect against Acrolein Toxicity in the Yeast Saccharomyces cerevisiae
Author(s) -
Eleanor W. Trotter,
Emma J. Collinson,
Ian W. Dawes,
Chris M. Grant
Publication year - 2006
Publication title -
applied and environmental microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.552
H-Index - 324
eISSN - 1070-6291
pISSN - 0099-2240
DOI - 10.1128/aem.00526-06
Subject(s) - acrolein , saccharomyces cerevisiae , biochemistry , mutant , enzyme , yeast , reactive oxygen species , chemistry , biology , gene , catalysis
Acrolein is a ubiquitous reactive aldehyde which is formed as a product of lipid peroxidation in biological systems. In this present study, we screened the complete set of viable deletion strains inSaccharomyces cerevisiae for sensitivity to acrolein to identify cell functions involved in resistance to reactive aldehydes. We identified 128 mutants whose gene products are localized throughout the cell. Acrolein-sensitive mutants were distributed among most major biological processes but particularly affected gene expression, metabolism, and cellular signaling. Surprisingly, the screen did not identify any antioxidants or similar stress-protective molecules, indicating that acrolein toxicity may not be mediated via reactive oxygen species. Most strikingly, a mutant lacking an old yellow enzyme (OYE2 ) was identified as being acrolein sensitive. Old yellow enzymes are known to reduce α,β-unsaturated carbonyl compounds in vitro, but their physiological roles have remained uncertain. We show that mutants lackingOYE2 , but notOYE3 , are sensitive to acrolein, and overexpression of both isoenzymes increases acrolein tolerance. Our data indicate thatOYE2 is required for basal levels of tolerance, whereasOYE3 expression is particularly induced following acrolein stress. Despite the range of α,β-unsaturated carbonyl compounds that have been identified as substrates of old yellow enzymes in vitro, we show that old yellow enzymes specifically mediate resistance to small α,β-unsaturated carbonyl compounds, such as acrolein, in vivo.